Abbott India EV/EBITDA
What is the EV/EBITDA of Abbott India?
The EV/EBITDA of Abbott India Limited is 43.60
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on BSE compared to Abbott India
What does Abbott India do?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
Companies with ev/ebitda similar to Abbott India
- PaySign has EV/EBITDA of 43.41
- B & D Strategic has EV/EBITDA of 43.44
- China Apex has EV/EBITDA of 43.47
- Xref has EV/EBITDA of 43.47
- AK Medical has EV/EBITDA of 43.51
- Escorts has EV/EBITDA of 43.55
- Abbott India has EV/EBITDA of 43.60
- ADC India Communications has EV/EBITDA of 43.63
- Elecon Engineering has EV/EBITDA of 43.68
- V.S. International has EV/EBITDA of 43.90
- Harvest Minerals has EV/EBITDA of 43.94
- Pritish Nandy Communications Ltd has EV/EBITDA of 43.96
- Satu has EV/EBITDA of 44.04